Werner Verbiest
Global Head, Janssen Diagnostics
Luc Truyen, MD, PhD.
Global Head of Development & External Affairs, Neuroscience Therapeutic Area – Janssen R&D, LLC
J.D. Alvarez, M.D., Ph.D.
Vice President, Oncology Diagnostics, for the Janssen Pharmaceutical Companies of Johnson & Johnson
Mariano Alvarez, PhD
Chief Scientific Officer, DarwinHealth™
Ashish Atreja, MD, MPH
Asst. Professor & Chief Innovation Officer, Icahn School of Medicine at Mount Sinai
Dina Avery, DHSc, MA, MAEd
Assistant Professor & Regulatory Affairs Specialist, University of Alabama at Birmingham
John M. Baldoni, PhD
Senior Vice President, In silico Drug Discovery, GSK Pharma R&D
Annette Bakker, Ph.D.
President and Chief Scientific Officer, the Children’s Tumor Foundation
Michele M. Becci, MBA
Vice President, Industry Strategy at Medidata Solutions
Christina Bender, PhD, MBA
Director, Global Diagnostic Pipeline Strategy – Novartis
Carol Berry, MBA
Senior Vice-President and Chief Business Officer, Caprion Biosciences Inc.
Wayne Caldwell
Director – Diaceutics Inc.
Jim Cassidy MD PhD
Corporate VP, Celgene
Gregory J. Downing, D.O., Ph.D.
Founder of Innovation Horizons, LLC
Ysabel Duron
Founder & Director, Latino Cancer Institute
Jim Fackler, M.D.
Associate Professor, Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine
Andrea Ferris
President & CEO, LUNGevity Foundation
Ryan Fukushima, MBA
Chief Operating Officer, Tempus
Anita Krithivas Gandhi, Ph.D
Senior Director, Translational Development and Diagnostics Department, Celgene Corporation
Marc Grodman, MD
Co-Founder & CEO, Genosity
Sarah Hersey, MS, MBA, RAC
Head of Precision Medicine and Companion Diagnostics, Celgene Corporation
Jeffrey R. Idle, PhD
Endowed Professor and Director, Arthur G. Zupko’s Systems Pharmacology and Pharmacogenomics, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University
Jay S Kaufman, Ph.D.
Professor, Department of Epidemiology, Biostatistics and Occupational Health, McGill University
Kevin Kalinsky, M.D., M.S
Assistant Professor of Medicine at the NewYork-Presbyterian Hospital/Columbia University Medical Center
Peter Kapitein, PhD
Founder Inspire2Live
Mark G. Kris, MD
Attending Physician, Thoracic Oncology Service, The William and Joy Ruane Chair in Thoracic Oncology, Lead Physician, Memorial Sloan Kettering–IBM Watson Collaboration
Eric B. Kmiec, Ph.D
Founder and Director of the Gene Editing Institute at the Helen F. Graham Cancer Center & Research Institute at Christiana Care Health System
Michael Kolodziej M.D.
Vice President and Chief Innovation Officer, ADVI Health
Andrew Kung, MD, PhD
Pediatric Oncologist, Chair, Department of Pediatrics, MSKCC
Arturo Loaiza-Bonilla, MD MSEd FACP
Chief of Medical Oncology and Medical Director of Research at Cancer Treatment Centers of America – ERMC, and also Co-Founder and Chief Medical Officer at Massive Bio
J Blake Long, MD, MBA
President, Long Health Care Consulting
Hannah Mamuszka
Founder and CEO of Alva10
Jennifer Manly, PhD
Associate Professor of Neuropsychology in Neurology at the Taub Institute for Research in Alzheimer’s Disease and the Aging Brain at Columbia University
Maurie Markman, MD
President of Medicine & Science at Cancer Treatment Centers of America.
Anne-Marie Martin Ph.D.
Senior Vice President and Global Head of Precision Medicine, Novartis
Glenn A. Miller, Ph.D.
Partners Healthcare Innovation’s Market Sector Leader for Radiology, Anesthesiology, Neurology, Neurosurgery and Psychiatry
Robert S. Miller, MD, FACP, FASCO
Vice President and Medical Director, CancerLinQ®
Spyro Mousses, PhD
Executive Scientific Advisor, Medical Intelligence and Innovation Institute Children’s Hospital of Orange County, CEO Systems Oncology
Melanie Nallicheri, MBA
Chief Business Officer and Head, Biopharma, Foundation Medicine